HCV IRES-Mediated Core Expression in Zebrafish

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zhao, Ye ^a   Qin, Wei ^a   Zhang, Jing Pu ^a   Hu, Zhan Ying ^a   Tong, Jun Wei ^a   Ding, Cun Bao ^a   Peng, Zong Gen ^a   Zhao, Li Xun ^a   Song, Dan Qing ^a   Jiang, Jian Dong ^b  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN RECEPTOR; ALPHA2B INTERFERON; CYANOCOBALAMIN; FATTY ACID BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; HEPARANASE; LIVER TRIACYLGLYCEROL LIPASE; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR A; RIBAVIRIN; TRANSFORMING GROWTH FACTOR BETA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FATTY LIVER; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC TRANSCRIPTION; HEPATITIS C; HEPATITIS C VIRUS; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; LIVER FIBROSIS; NONHUMAN; PROTEIN DEGRADATION; RNA TRANSLATION; ZEBRA FISH;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-ALPHA; LARVA; LIVER; MUTANT CHIMERIC PROTEINS; RECOMBINANT PROTEINS; RIBAVIRIN; RNA, MESSENGER; VIRAL CORE PROTEINS; VITAMIN B 12; ZEBRAFISH;

EID: 84874580540     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056985     Document Type: Article

References (49)

1. Lavanchy D, (2011) Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection 17: 107-115.
2. Asselah T, Estrabaud E, Bieche I, Lapalus M, De Muynck S, et al. (2010) Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin. Liver International 30: 1259-1269.
3. Thompson AJ, McHutchison JG, (2009) Antiviral resistance and specifically targeted therapy for HCV (STAT-C). J Viral Hepat 16: 377-387.
4. Qiu P, Sanfiorenzo V, Curry S, Guo Z, Liu S, et al. (2009) Identification of HCV protease inhibitor resistance mutations by selection pressure-based method. Nucleic Acids Res 37: e74.
5. Susser S, Welsch C, Wang Y, Zettler M, Domingues FS, et al. (2009) Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients. Hepatology 50: 1709-1718.
6. Kuntzen T, Timm J, Berical A, Lennon N, Berlin AM, et al. (2008) Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology 48: 1769-1778.
7. Yanagi M, Purcell RH, Emerson SU, Bukh J, (1997) Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proceedings of the National Academy of Sciences of the United States of America 94: 8738-8743.
8. Mercer DF, Schiller DE, Elliott JF, Douglas DN, Hao C, et al. (2001) Hepatitis C virus replication in mice with chimeric human livers. Nature medicine 7: 927-933.
9. Tan SL, Pause A, Shi Y, Sonenberg N, (2002) Hepatitis C therapeutics: current status and emerging strategies. Nature Reviews Drug Discovery 1: 867-881.
10. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, et al. (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359-362.
11. Suzuki T, Ishii K, Aizaki H, Wakita T, (2007) Hepatitis C viral life cycle. Advanced Drug Delivery Reviews 59: 1200-1212.
12. Kim KH, Hong SP, Kim KJ, Park MJ, Cheong JH, (2007) HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPAR [gamma]. Biochemical and biophysical research communications 355: 883-888.
13. Yamaguchi A, Tazuma S, Nishioka T, Ohishi W, Hyogo H, et al. (2005) Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Digestive diseases and sciences 50: 1361-1371.
14. Jackel-Cram C, Babiuk LA, Liu Q, (2007) Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core. J Hepatol 46: 999-1008.
15. Tachi Y, Katano Y, Honda T, Hayashi K, Ishigami M, et al. (2010) Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C. Liver International. 30: 554-559.
16. Mee CJ, Farquhar MJ, Harris HJ, Hu K, Ramma W, et al. (2010) Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner. Gastroenterology 138: 1134-1142.
17. Fukuhara T, Takeishi K, Toshima T, Morita K, Ueda S, et al. (2010) Impact of amino acid substitutions in the core region of HCV on multistep hepatocarcinogenesis. Hepatology Research 40: 171-178.
18. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, et al. (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proceedings of the National Academy of Sciences 87: 6547-6549.
19. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A, (1992) Internal ribosome entry site within hepatitis C virus RNA. Journal of virology 66: 1476-1483.
20. Reynolds JE, Kaminski A, Carroll A, Clarke BE, Rowlands DJ, et al. (1996) Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon. RNA 2: 867-878.
21. Lieschke GJ, Currie PD, (2007) Animal models of human disease: zebrafish swim into view. Nature Reviews Genetics 8: 353-367.
22. Lam SH, Wu YL, Vega VB, Miller LD, Spitsbergen J, et al. (2005) Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nature biotechnology 24: 73-75.
23. Chu J, Sadler KC, (2009) New school in liver development: lessons from zebrafish. Hepatology 50: 1656-1663.
24. Shieh YS, Chang YS, Hong JR, Chen LJ, Jou LK, et al. (2010) Increase of hepatic fat accumulation by liver specific expression of Hepatitis B virus X protein in zebrafish. Biochim. Biophys. Acta 1801: 721-730.
25. Rekha RD, Amali AA, Her GM, Yeh YH, Gong HY, et al. (2008) Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio. Toxicology 243: 11-22.
26. Ding CB, Zhang JP, Zhao Y, Peng ZG, Song DQ, et al. (2011) Zebrafish as a Potential Model Organism for Drug Test against Hepatitis C Virus. PLoS ONE 6: e22921.
27. Van Deursen D, Botma GJ, Jansen H, Verhoeven AJ, (2007) Comparative genomics and experimental promoter analysis reveal functional liver-specific elements in mammalian hepatic lipase genes. BMC Genomics 8: 99.
28. Her GM, Yeh YH, Wu JL, (2003) 435-bp liver regulatory sequence in the liver fatty acid binding protein (L-FABP) gene is sufficient to modulate liver regional expression in transgenic zebrafish. Dev Dyn 227: 347-356.
29. Kohjima M, Enjoji M, Higuchi N, Kato M, Kotoh K, et al. (2007) Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. International journal of molecular medicine 20: 351-358.
30. Fujino T, Nakamuta M, Yada R, Aoyagi Y, Yasutake K, et al. (2010) Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver. Hepatol Res 40: 923-929.
31. Smith DB, Mellor J, Jarvis LM, Davidson F, Kolberg J, et al. (1995) Variation of the hepatitis C virus 5'non-coding region: implications for secondary structure, virus detection and typing. Journal of general virology 76: 1749-1761.
32. Reynolds J, Kaminski A, Kettinen H, Grace K, Clarke B, et al. (1995) Unique features of internal initiation of hepatitis C virus RNA translation. The EMBO journal 14: 6010-6020.
33. Li D, Lott WB, Martyn J, Haqshenas G, Gowans EJ, (2004) Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein. Journal of virology 78: 12075-12081.
34. Zhang J, Yamada O, Yoshida H, Iwai T, Araki H, (2002) Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus. Virology 293: 141-150.
35. Lukavsky PJ, (2009) Structure and function of HCV IRES domains. Virus research 139: 166-171.
36. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, et al. (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nature medicine 4: 1065-1067.
37. Nishimura-Sakurai Y, Sakamoto N, Mogushi K, Nagaie S, Nakagawa M, et al. (2010) Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells. Journal of gastroenterology 45: 523-536.
38. Singaravelu R, Blais DR, McKay CS, Pezacki JP, (2010) Activity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe. Proteome Science 8: 5.
39. Li D, Lott WB, Martyn J, Haqshenas G, Gowans EJ, (2004) Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein. Journal of virology 78: 12075-12081.
40. Lott WB, Takyar SS, Tuppen J, Crawford DHG, Harrison M, et al. (2001) Vitamin B12 and hepatitis C: molecular biology and human pathology. Proceedings of the National Academy of Sciences of the United States of America 98: 4916-4921.
41. Takyar SS, Gowans EJ, Lott WB, (2002) Vitamin B12 stalls the 80 S ribosomal complex on the hepatitis C internal ribosome entry site. Journal of molecular biology 319: 1-8.
42. Paulsen RB, Seth PP, Swayze EE, Griffey RH, Skalicky JJ, et al. (2010) Inhibitor-induced structural change in the HCV IRES domain IIa RNA. Proceedings of the National Academy of Sciences 107: 7263-7268.
43. Locker N, Easton LE, Lukavsky PJ, (2007) HCV and CSFV IRES domain II mediate eIF2 release during 80S ribosome assembly. The EMBO journal 26: 795-805.
44. Wang W, Préville P, Morin N, Mounir S, Cai W, et al. (2000) Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules. Bioorganic & medicinal chemistry letters 10: 1151-1154.
45. Liua S, Nelsona CA, Li X, Lua L, Sethd PP, et al. (2011) Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase. Antiviral Research 89: 54-63.
46. Dumas E, Staedel C, Colombat M, Reigadas S, Chabas S, et al. (2003) A promoter activity is present in the DNA sequence corresponding to the hepatitis C virus 5′ UTR. Nucleic Acids Res 31: 1275-1281.
47. Dash S, Prabhu R, Hazari S, Bastian F, Garry R, et al. (2005) Interferons α, β, γ each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation. Liver International 25: 580-594.
48. Wang Z, He Z, Wu Z, Zhang W, (2000) Induction of apoptosis in human hepatocellular carcinoma cells by adenoviral-mediated transfer of human multigenes, Chin J Hepatol. 8: 224-226.
49. Thisse C, Thisse B, (2007) High-resolution in situ hybridization to whole-mount zebrafish embryos. Nature Protocols 3: 59-69.